Syra Health Corp. Class A Common Stock (SYRA)
USD 0.11
(-15.34%)
USD 0.11
(-15.34%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -2.83 Million USD | -36.68% |
| 2022 | -2.07 Million USD | -67416.53% |
| 2021 | -3073.00 USD | 28.03% |
| 2020 | -4270.00 USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -1.37 Million USD | 4.28% |
| 2024 Q3 | -428.91 Thousand USD | 71.54% |
| 2024 Q1 | -1.39 Million USD | -46.91% |
| 2023 Q1 | -748.73 Thousand USD | -25.41% |
| 2023 Q4 | -973.68 Thousand USD | -197.0% |
| 2023 FY | - USD | -36.68% |
| 2023 Q3 | -327.83 Thousand USD | 57.51% |
| 2023 Q2 | -771.65 Thousand USD | -3.06% |
| 2022 Q1 | -519.96 Thousand USD | 0.0% |
| 2022 FY | - USD | -67416.53% |
| 2022 Q4 | -597.03 Thousand USD | -74.11% |
| 2022 Q3 | -342.91 Thousand USD | 44.8% |
| 2022 Q2 | -621.27 Thousand USD | -19.48% |
| 2021 FY | - USD | 28.03% |
| 2020 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 189.11 Million USD | 101.5% |
| Addus HomeCare Corporation | 106.55 Million USD | 102.661% |
| AirSculpt Technologies, Inc. | 28.31 Million USD | 110.017% |
| Amedisys, Inc. | 216.91 Million USD | 101.307% |
| American Oncology Network, Inc. | -39.35 Million USD | 92.793% |
| Astrana Health, Inc. | 123.68 Million USD | 102.293% |
| Aveanna Healthcare Holdings Inc. | 44.34 Million USD | 106.395% |
| IMAC Holdings, Inc. | -5.94 Million USD | 52.312% |
| biote Corp. | 9.23 Million USD | 130.711% |
| Cryo-Cell International, Inc. | -10.41 Million USD | 72.777% |
| Cross Country Healthcare, Inc. | 129.33 Million USD | 102.193% |
| COMPASS Pathways plc | -123.8 Million USD | 97.709% |
| DocGo Inc. | 32.72 Million USD | 108.666% |
| The Ensign Group, Inc. | 353.23 Million USD | 100.803% |
| Healthcare Services Group, Inc. | 75.21 Million USD | 103.771% |
| InnovAge Holding Corp. | 1.15 Million USD | 345.744% |
| Assure Holdings Corp. | -19.82 Million USD | 85.695% |
| The Joint Corp. | 9.14 Million USD | 131.021% |
| LifeStance Health Group, Inc. | -104.92 Million USD | 97.297% |
| Mobile-health Network Solutions Class A Ordinary Shares | -15.55 Million USD | 81.768% |
| ModivCare Inc. | -26.75 Million USD | 89.399% |
| NewGenIvf Group Limited | 384.3 Thousand USD | 837.926% |
| Novo Integrated Sciences, Inc. | -5.84 Million USD | 51.515% |
| Option Care Health, Inc. | 376.79 Million USD | 100.753% |
| P3 Health Partners Inc. | -81.07 Million USD | 96.502% |
| P3 Health Partners Inc. | -81.07 Million USD | 96.502% |
| The Pennant Group, Inc. | 30.36 Million USD | 109.338% |
| Surgery Partners, Inc. | 446.1 Million USD | 100.636% |
| Talkspace, Inc. | -22.01 Million USD | 87.117% |
| Talkspace, Inc. | -22.01 Million USD | 87.117% |
| The Oncology Institute, Inc. | -70.45 Million USD | 95.975% |
| The Oncology Institute, Inc. | -70.45 Million USD | 95.975% |